Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Drawing First Blood

Two experts to debate controversial topics in hematology and health care.
Where to Start: BTK Inhibitors or Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia?
Emma Yasinski
November 26, 2024
Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?
Leah Lawrence
November 21, 2024
Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?
Leah Lawrence
September 26, 2024
Which Inhibitor Should Be Used to Treat FLT3-Positive AML?
Emma Yasinski
June 20, 2024
Should Iron Deficiency Be Treated With Oral or IV Iron?
Emma Yasinski
February 2, 2024
Will Pola-R-CHP Be the New Standard Upfront Treatment for Diffuse Large B-Cell Lymphoma?
September 27, 2023
Are Hypomethylating Agents the Best First-Line Choice for Treating CMML?
Leah Lawrence
June 29, 2023
Which Modality Is Preferred in Hemophilia: Factor or Non-Factor Prophylaxis?
Kimberly J. Retzlaff
February 17, 2023
Clonal Cytopenia of Unknown Significance: To Treat or Not To Treat?
Kimberly Retzlaff
June 24, 2022
In Heparin-Induced Thrombocytopenia, Is Screening Four Extremities Better Than Screening Two?
Kimberly Retzlaff
February 22, 2022
Has ABIM Gone Too Far?
December 30, 2021
Is There Still a Need for Radiation Therapy in Hodgkin Lymphoma?
December 30, 2021
To Transplant or Not To Transplant in First Remission?
December 30, 2021
Rituximab or Splenectomy in Steroid-Resistant ITP Patients?
December 30, 2021
Is Fludarabine Dead in CLL?
December 30, 2021
For Anticoagulation in Cancer-Associated Thrombosis, Is Less More?
December 30, 2021
Should IVC Filters Still Be Inserted into Thrombosis Management Guidelines?
December 30, 2021
Optimal Timing of Transplant in Myeloma
December 30, 2021
Choosing Between Treatment Strategies for Patients With Acquired Hemophilia A
December 30, 2021
To Test or Not to Test: Is Pharmacogenomic Testing for Warfarin Valuable?
December 30, 2021

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
March 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals